Leriglitazone Uses, Dosage, Side Effects and more
Leriglitazone is under investigation in clinical trial NCT03917225 (A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients).
| Trade Name | Leriglitazone |
| Generic | Leriglitazone |
| Leriglitazone Other Names | Leriglitazone |
| Type | |
| Formula | C19H20N2O4S |
| Weight | Average: 372.438 Monoisotopic: 372.114377828 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
